Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 157

1.

Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis.

Pender MP, Csurhes PA, Smith C, Douglas NL, Neller MA, Matthews KK, Beagley L, Rehan S, Crooks P, Hopkins TJ, Blum S, Green KA, Ioannides ZA, Swayne A, Aftab BT, Hooper KD, Burrows SR, Thompson KM, Coulthard A, Khanna R.

JCI Insight. 2018 Nov 15;3(22). pii: 124714. doi: 10.1172/jci.insight.124714.

2.

PLP1 Mutations in Patients with Multiple Sclerosis: Identification of a New Mutation and Potential Pathogenicity of the Mutations.

Cloake NC, Yan J, Aminian A, Pender MP, Greer JM.

J Clin Med. 2018 Oct 11;7(10). pii: E342. doi: 10.3390/jcm7100342.

3.

Increased constitutive activation of NF-κB p65 (RelA) in peripheral blood cells of patients with progressive multiple sclerosis.

Yan J, Winterford CM, Catts VS, Pat BK, Pender MP, McCombe PA, Greer JM.

J Neuroimmunol. 2018 Jul 15;320:111-116. doi: 10.1016/j.jneuroim.2018.04.002. Epub 2018 Apr 6.

PMID:
29655870
4.

Erratum: Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis.

Pender MP, Csurhes PA, Burrows JM, Burrows SR.

Clin Transl Immunology. 2017 Jun 16;6(6):e147. doi: 10.1038/cti.2017.25. eCollection 2017 Jun.

5.

Incidence and prevalence of NMOSD in Australia and New Zealand.

Bukhari W, Prain KM, Waters P, Woodhall M, O'Gorman CM, Clarke L, Silvestrini RA, Bundell CS, Abernethy D, Bhuta S, Blum S, Boggild M, Boundy K, Brew BJ, Brown M, Brownlee WJ, Butzkueven H, Carroll WM, Chen C, Coulthard A, Dale RC, Das C, Dear K, Fabis-Pedrini MJ, Fulcher D, Gillis D, Hawke S, Heard R, Henderson APD, Heshmat S, Hodgkinson S, Jimenez-Sanchez S, Killpatrick T, King J, Kneebone C, Kornberg AJ, Lechner-Scott J, Lin MW, Lynch C, Macdonell R, Mason DF, McCombe PA, Pender MP, Pereira JA, Pollard JD, Reddel SW, Shaw C, Spies J, Stankovich J, Sutton I, Vucic S, Walsh M, Wong RC, Yiu EM, Barnett MH, Kermode AG, Marriott MP, Parratt JDE, Slee M, Taylor BV, Willoughby E, Wilson RJ, Vincent A, Broadley SA.

J Neurol Neurosurg Psychiatry. 2017 Aug;88(8):632-638. doi: 10.1136/jnnp-2016-314839. Epub 2017 May 26.

6.

Reactivity to Novel Autoantigens in Patients with Coexisting Central Nervous System Demyelinating Disease and Autoimmune Thyroid Disease.

Greer JM, Broadley S, Pender MP.

Front Immunol. 2017 May 8;8:514. doi: 10.3389/fimmu.2017.00514. eCollection 2017.

7.

Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis.

Pender MP, Csurhes PA, Burrows JM, Burrows SR.

Clin Transl Immunology. 2017 Jan 20;6(1):e126. doi: 10.1038/cti.2016.87. eCollection 2017 Jan. Erratum in: Clin Transl Immunology. 2017 Jun 16;6(6):e147.

8.

Stressful life events and the risk of initial central nervous system demyelination.

Saul A, Ponsonby AL, Lucas RM, Taylor BV, Simpson S Jr, Valery P, Dwyer T, Kilpatrick TJ, Pender MP, van der Mei IA.

Mult Scler. 2017 Jun;23(7):1000-1007. doi: 10.1177/1352458516667566. Epub 2016 Sep 6.

PMID:
27600112
9.

Population attributable fractions and joint effects of key risk factors for multiple sclerosis.

van der Mei I, Lucas RM, Taylor BV, Valery PC, Dwyer T, Kilpatrick TJ, Pender MP, Williams D, Chapman C, Otahal P, Ponsonby AL.

Mult Scler. 2016 Apr;22(4):461-9. doi: 10.1177/1352458515594040. Epub 2015 Jul 21.

PMID:
26199349
10.

Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapy.

Pender MP, Burrows SR.

Clin Transl Immunology. 2014 Oct 31;3(10):e27. doi: 10.1038/cti.2014.25. eCollection 2014 Oct. Review.

11.

Epstein-Barr virus-specific adoptive immunotherapy: a new horizon for multiple sclerosis treatment?

Pender MP, Khanna R.

Immunotherapy. 2014;6(6):659-61. doi: 10.2217/imt.14.43. No abstract available.

12.

Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosis.

Pender MP, Csurhes PA, Pfluger CM, Burrows SR.

Mult Scler. 2014 Dec;20(14):1825-32. doi: 10.1177/1352458514536252. Epub 2014 May 19.

13.

Elevated levels of autoantibodies targeting the M1 muscarinic acetylcholine receptor and neurofilament medium in sera from subgroups of patients with schizophrenia.

Jones AL, Mowry BJ, McLean DE, Mantzioris BX, Pender MP, Greer JM.

J Neuroimmunol. 2014 Apr 15;269(1-2):68-75. doi: 10.1016/j.jneuroim.2014.02.008. Epub 2014 Feb 25.

PMID:
24636402
14.

Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.

Pender MP, Csurhes PA, Smith C, Beagley L, Hooper KD, Raj M, Coulthard A, Burrows SR, Khanna R.

Mult Scler. 2014 Oct;20(11):1541-4. doi: 10.1177/1352458514521888. Epub 2014 Feb 3.

15.

The physical anthropometry, lifestyle habits and blood pressure of people presenting with a first clinical demyelinating event compared to controls: the Ausimmune study.

Ponsonby AL, Lucas RM, Dear K, van der Mei I, Taylor B, Chapman C, Coulthard A, Dwyer T, Kilpatrick TJ, McMichael AJ, Pender MP, Valery PC, Williams D.

Mult Scler. 2013 Nov;19(13):1717-25. doi: 10.1177/1352458513483887. Epub 2013 May 13.

PMID:
23670542
16.

Early-life hygiene-related factors affect risk of central nervous system demyelination and asthma differentially.

Hughes AM, Lucas RM, McMichael AJ, Dwyer T, Pender MP, van der Mei I, Taylor BV, Valery P, Chapman C, Coulthard A, Dear K, Kilpatrick TJ, Williams D, Ponsonby AL.

Clin Exp Immunol. 2013 Jun;172(3):466-74. doi: 10.1111/cei.12077.

17.

Occupational exposure and risk of central nervous system demyelination.

Valery PC, Lucas RM, Williams DB, Pender MP, Chapman C, Coulthard A, Dear K, Dwyer T, Kilpatrick TJ, McMichael AJ, van der Mei I, Taylor BV, Ponsonby AL.

Am J Epidemiol. 2013 May 1;177(9):954-61. doi: 10.1093/aje/kws361. Epub 2013 Apr 12.

PMID:
23585328
18.

Vitamin D status: multifactorial contribution of environment, genes and other factors in healthy Australian adults across a latitude gradient.

Lucas RM, Ponsonby AL, Dear K, Valery PC, Taylor B, van der Mei I, McMichael AJ, Pender MP, Chapman C, Coulthard A, Kilpatrick TJ, Stankovich J, Williams D, Dwyer T.

J Steroid Biochem Mol Biol. 2013 Jul;136:300-8. doi: 10.1016/j.jsbmb.2013.01.011. Epub 2013 Feb 8. Review.

PMID:
23395985
19.

Sun exposure over a lifetime in Australian adults from latitudinally diverse regions.

Lucas RM, Valery P, van der Mei I, Dwyer T, Pender MP, Taylor B, Ponsonby AL; Ausimmune Investigator Group.

Photochem Photobiol. 2013 May-Jun;89(3):737-44. doi: 10.1111/php.12044. Epub 2013 Feb 19.

PMID:
23311500
20.

CD8+ T cells far predominate over CD4+ T cells in healthy immune response to Epstein-Barr virus infected lymphoblastoid cell lines.

Pender MP, Csurhes PA, Pfluger CM, Burrows SR.

Blood. 2012 Dec 13;120(25):5085-7. doi: 10.1182/blood-2012-06-437285. No abstract available.

PMID:
23243157

Supplemental Content

Loading ...
Support Center